Abstract:The removal of poly(A) tail from mRNA sequences reduces their stability and translational activity. The deadenylation process is mainly regulated by the CCR4-NOT complex for which potent chemical inhibitors are rare. The subunit NOT9 binds various RNA binding proteins (RBPs) which recruit mRNA in a sequence-specific manner to the CCR4-NOT complex to promote their deadenylation. Several of these RBPs interact with NOT9 through an evolutionary conserved (C)NOT9 binding motif (CBM) which we used as a starting point for inhibitor design. A potent hydrocarbon stapled peptide (NIP-2) with a 60 nM binding affinity for NOT9 was identified and able to inhibit the deadenylation activity of the CCR4-NOT complex on poly(A) RNA in vitro. A co-crystal structure of NIP-2 bound to NOT9 was obtained and allowed further optimization of the peptide through point mutation which led to a variant with high cell permeability. The optimized NIP-2-H27A-N3 was able to increase the poly(A) tail length of target mRNAs by inhibiting the deadenylation activity of the CCR4-NOT complex in cells demonstrating the feasibility of increasing mRNA stability using deadenylation inhibitors.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to develop a small - molecule inhibitor that can specifically inhibit the activity of the NOT9 subunit in the CCR4 - NOT complex, in order to regulate the mRNA deadenylation process and further affect the stability and half - life of mRNA. Specifically, the authors focus on preventing the CCR4 - NOT complex from deadenylating mRNA by inhibiting the interaction between the NOT9 subunit and RNA - binding proteins (RBPs) or other RNA molecules, thereby protecting mRNA from being prematurely degraded. ### Background Introduction The stability of mRNA is crucial for its efficiency in being translated into proteins. The degradation of mRNA in the cytoplasm is a strictly regulated process, in which deadenylation (i.e., the removal of the poly(A) tail at the 3' end of mRNA) is the main rate - limiting step. The CCR4 - NOT complex is one of the key enzyme complexes responsible for this process. However, there are currently very few effective chemical inhibitors targeting the CCR4 - NOT complex, which limits the research on the regulatory mechanisms of mRNA stability and potential therapeutic applications. ### Research Objectives The researchers' goal is to design and synthesize an inhibitor that can specifically bind to the NOT9 subunit, especially by mimicking the interaction between the NOT9 subunit and its natural ligands (such as specific RNA - binding proteins). This inhibitor needs to be not only effective in vitro but also have good cell permeability so as to function inside cells. ### Main Findings - **Design and Screening**: Through structure - guided design methods, the researchers synthesized α - helical peptides based on the CBM domain of the Drosophila melanogaster Bam protein and obtained the inhibitor NIP - 2 with high affinity (low nanomolar level) through a series of optimizations. - **Functional Verification**: NIP - 2 can not only effectively compete for the binding of NOT9 to RNA or its natural ligands, but also significantly inhibit the deadenylation activity of the CCR4 - NOT complex on mRNA in vitro. - **Cell Experiments**: Further cell experiments showed that the optimized NIP - 2 variant NIP - 2 - H27A can increase the length of the poly(A) tail of the target mRNA in cells, thus demonstrating the feasibility of improving mRNA stability by inhibiting deadenylation. In summary, this study provides an important basis for the development of new mRNA stability regulators. Especially in the field of disease treatment, such as cancer treatment, controlling gene expression by regulating the stability of specific mRNAs may have important application values.

Targeting the NOT9 subunit of the CCR4-NOT complex inhibits mRNA deadenylation

Stapled Peptides as Inhibitors of mRNA Deadenylation

Deadenylation kinetics of mixed poly(A) tails at single-nucleotide resolution

Structural Basis of M(7)Gpppg Binding to Poly(A)-Specific Ribonuclease

Structural Basis of the PNRC2-mediated Link Between Mrna Surveillance and Decapping.

Crystal Structure of PARN in Complex with Cap Analogue

Specific recognition and ubiquitination of slow-moving ribosomes by human CCR4-NOT

Crystal Structure of Dcp1p and Its Functional Implications in Mrna Decapping

Poly(A)-Specific Ribonuclease (parn): Molecular Mechanisms of Mrna Cap and Poly(A) Tail Recognition

Structural and Functional Insights into Eukaryotic Mrna Decapping

Phosphorylation-dependent tuning of mRNA deadenylation rates

Structural and Functional Control of the Eukaryotic Mrna Decapping Machinery

Not1 and Not4 inversely determine mRNA solubility that sets the dynamics of co-translational events

The Ccr4-Not complex monitors the translating ribosome for codon optimality

Roles of mRNA fate modulators Dhh1 and Pat1 in TNRC6-dependent gene silencing recapitulated in yeast

Structure of the human Ccr4-Not nuclease module using X-ray crystallography and electron paramagnetic resonance spectroscopy distance measurements

Structure and function of molecular machines involved in deadenylation-dependent 5′-3′ mRNA degradation

DMDA-PatA mediates RNA sequence-selective translation repression by anchoring eIF4A and DDX3 to GNG motifs

Structure of the Dom34–Hbs1 Complex and Implications for No-Go Decay

Rational design of an artificial tethered enzyme for non-templated post-transcriptional mRNA polyadenylation by the second generation of the C3P3 system

Crystal structure of the human CNOT6L nuclease domain reveals strict poly(A) substrate specificity.